Amy Guo, PhD

Ferring Pharmaceuticals

Poster(s):

• E0348 - Health-Related Quality of Life of Week 8 Responders and Non-Responders: Results from the RBX2660 Phase 3 Randomized, Placebo-Controlled Trial in Recurrent Clostridioides difficile Infection (PUNCH CD3)
  Tuesday, October 25, 2022

  3:00 PM – 5:00 PM ET

• E0349 - Health-Related Quality of Life in Patients With One Prior Episode of Recurrent Clostridioides difficile Infection (rCDI): Results from the RBX2660 Phase 3 Randomized, Placebo-Controlled rCDI Trial (PUNCH CD3)
  Tuesday, October 25, 2022

  3:00 PM – 5:00 PM ET